Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products
May 19, 2021
Ryan Allway May 19th, 2021 Psychedelics Vancouver, British Columbia–(Newsfile Corp. – May 19, 2021) – Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe“) is pleased to announce it has entered into a production and supply agreement (the “Agreement”) on May 14, 2021 with HAVN Life Sciences Inc. (CSE:... Read more
Ryan Allway May 4th, 2021 Psychedelics Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) – Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe“) is pleased to announce that it has acquired, through its wholly owned subsidiary Eleusian Biosciences Corp. (“Eleusian“), the consumer goods product line, “Vitamind”, pursuant to... Read more
